EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Changing Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment

Nicolò Bertalmio iD, Francesca Anna Lourdes Marino, Serena Brundu, Serena Rustichelli iD, Enrico Giraudo iD

International Journal of Molecular Sciences · 31.10.2026 · 27 (21) · 9788

DOI: 10.3390/ijms27219788 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.10.2026. Verfasst von Nicolò Bertalmio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Microenvironment Laboratory, INOC-Istituto Nazionale Oncologico Candiolo, IRCCS, 10060 Candiolo, Turin, Italy. Hauptthemen laut MEDLINE: Semaphorins, Tumor Microenvironment, Pancreatic Neoplasms, Nerve Tissue Proteins. Die Arbeit nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Ministry of Education, Universities and Research, Ministry of Universities and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest solid tumors, and despite recent advances in surgical and systemic therapies, outcomes remain poor, rooted as much in the genetic mutations that initiate the disease as in a fibrotic, poorly vascularized microenvironment marked by scarce immune infiltration and a dense network of nerve fibers. Semaphorins, together with their receptors plexins and co-receptors neuropilins, have emerged as pivotal orchestrators of this microenvironment, shaping crosstalk between malignant cells, fibroblasts, macrophages, the endothelium, and peripheral neurons. This review examines how individual semaphorin family members drive, or in select contexts restrain, stromal activation, immune exclusion, pathological angiogenesis and neural remodeling. Building on this mechanistic framework, we explore the clinical relevance that semaphorin-mediated signaling holds for PDAC, from its potential as a prognostic and predictive biomarker to its growing promise as a therapeutic target, positioning this axis as a compelling frontier for improving outcomes in a disease that has long resisted meaningful therapeutic advances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SemaphorinsTumor MicroenvironmentPancreatic NeoplasmsNerve Tissue ProteinsCarcinoma, Pancreatic DuctalCell Adhesion MoleculesHumansAnimalsSignal TransductionNeovascularization, Pathologic

Stichwörter der Autor:innen

Semaphorins and Plexinspancreatic ductal adenocarcinomatumor microenvironment

Substanzen

SemaphorinsplexinNerve Tissue ProteinsCell Adhesion Molecules

Autor:innen und Institutionen

  • Tumor Microenvironment Laboratory, INOC-Istituto Nazionale Oncologico Candiolo, IRCCS, 10060 Candiolo, Turin, Italy.
  • Department of Science and Drug Technology, University of Turin, 10125 Turin, Italy.

ORCID-Profile: Nicolò Bertalmio, Serena Rustichelli, Enrico Giraudo

Förderung

  • Italian Association for Cancer Research
  • Ministry of Education, Universities and Research
  • Ministry of Universities and Research
  • Fondazione AIRC per la Ricerca sul Cancro
  • Italian Ministry of University and Research
  • Italian Ministry of Health, Ricerca Corrente
  • Fondazione Nadia Valsecchi

Zitieren

APA

Bertalmio, N., Marino, F. A. L., Brundu, S., Rustichelli, S., & Giraudo, E. (2026). Changing Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment. International Journal of Molecular Sciences, 27(21), 9788. https://doi.org/10.3390/ijms27219788

Vancouver

Bertalmio N, Marino FAL, Brundu S, Rustichelli S, Giraudo E. Changing Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment. International Journal of Molecular Sciences. 2026;27(21):9788. doi:10.3390/ijms27219788

BibTeX
@article{Bertalmio2026,
  author = {Bertalmio, Nicolò and Marino, Francesca Anna Lourdes and Brundu, Serena and Rustichelli, Serena and Giraudo, Enrico},
  title = {Changing Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9788},
  doi = {10.3390/ijms27219788}
}
Kostenlos starten →